Expanding Treatment Options for Advanced- and Early-Stage HR+/HER2- Breast Cancer

Chair, Erika Hamilton, MD, William J. Gradishar, MD, FASCO, FACP, Hope S. Rugo, MD, FASCO, and Professor Peter Schmid, FRCP, MD, PhD, discuss breast cancer in this CME/MOC activity titled “Clarifying the Complexities of the Expanding Treatment Options for Advanced- and Early-Stage HR+/HER2- Breast Cancer.” For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC information, and to apply for credit, please visit us at PeerView.com/YNC865. CME/MOC credit will be available until January 6, 2024.

свернуть